Detailed price information for Enanta Pharmaceutica (ENTA-Q) from The Globe and Mail including charting and trades.

Buying $100 In ABBV: If an investor had bought $100 of ABBV stock 5 years ago, it would be worth $212.70 today based on a price of $204.94 for ABBV at the time of writing.

President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the ...

This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are ...

In addition to Cantor Fitzgerald, AbbVie also received a Buy from Piper Sandler’s David Amsellem in a report issued yesterday. However, on August 4, Bernstein maintained a Hold rating on AbbVie (NYSE: ...

The two biggest weight-loss drugmakers have lost $252bn in value this year, as investor enthusiasm for obesity treatments wanes and Donald Trump’s tariff and price-cut threats weigh on the ...

Avalo Therapeutics (NASDAQ:AVTX) stock rises as Cantor Fitzgerald launches coverage with an Overweight rating, highlighting its lead asset, AVTX-009. Read more here.

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal.

Mastercard (MA) was the least shorted S&P 500 (SP500) stock as a percentage of float in July. The payment card services firm ...